tirzepatide surmount-1 weight loss percent 72 weeks as Compared with Semaglutide for the Treatment of Obesity SURMOUNT‐1 study design. This is

Healthcare providers can adjust the treatment regimen by slowing dose escalation, temporarily reducing the dose, or prescribing antiemetic medications when appropriate

Yes, tirzepatide functions equally well regardless of injection time

62 Different ligands lead to different interaction patterns with the receptor, generating various effects

It's important to note that tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis, as its effects on gastric emptying may worsen these conditions

However, other side effects can be more uncommon but potentially serious

Subjectively, adequate B12 manifests as maintained energy levels, absence of neurological symptoms like numbness or tingling, and normal cognitive function